BG
Last reporting period 30 Sep, 2023
Updated 18 Sep, 2024
Last price
—
Market cap $B
0.008
Exchange
XNAS - Nasdaq
-840 %
Last period Average growth rate (2y)
What is Average growth rate (2y) ?
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
See also BioNexus Gene
Company Analysis
BGLC valuation, rating, competitors, insights and company profile
Eyestock Rating
BGLC financial analysis by Eyestock methodology
Valuation
BGLC valuation using historical relative method
Statements
BGLC Income Statements, Balance Sheet and Cash Flow Statements
Dividends
BGLC dividend yield and annual dividend
An indicator of the average growth rate of the company's profit relative to the same periods of previous years in the medium-term retrospective.
BioNexus Gene`s Average growth rate (2y) for the period ended 2023-09-30 is -840 %
